Skip to content

Clinical trials

Cardiomyopathies trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Country / region: Japan Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20181
20192
20201
20231
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed3
Unknown status2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals4
Bristol-Myers Squibb1
Eidos Therapeutics, a BridgeBio company1
Hiroaki Shimokawa, MD, PhD1
Intellia Therapeutics1
Ionis Pharmaceuticals, Inc.1
Osaka City University1
Suzuka Hospital1
University of California, Los Angeles1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies12
Amyloidosis7
Amyloidosis, Familial2
Alzheimer Disease1
Amyloid Neuropathies, Familial1
Arrhythmias, Cardiac1
Cardiac Conduction System Disease1
Cardiomyopathy, Hypertrophic1
Coronary Disease1
Death, Sudden, Cardiac1

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.